Adar1 Capital Management, LLC Spero Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $441 Billion
- Q1 2024
A detailed history of Adar1 Capital Management, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 926,929 shares of SPRO stock, worth $1.3 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
926,929
Previous 1,067,711
13.19%
Holding current value
$1.3 Million
Previous $1.57 Billion
1.58%
% of portfolio
0.36%
Previous 0.56%
Shares
2 transactions
Others Institutions Holding SPRO
# of Institutions
53Shares Held
15.4MCall Options Held
19.6KPut Options Held
0-
Anson Funds Management LP Dallas, TX3.75MShares$5.25 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$2.31 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.89 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$1.25 Million0.07% of portfolio
-
Murchinson Ltd. Toronto, A6874KShares$1.22 Million0.13% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $49.1M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...